<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="../../css/uswds.min.css">
    <link rel="stylesheet" href="../../css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="../../index.html">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="../../index.html">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="../titles/title21.html">
                                    Title 21
                                </a><span>&nbsp/&nbsp</span>
                                <a href="../parts/21CFR1271.html">Part 1271
                                </a><span>&nbsp/&nbsp<span>
                                Sec. 1271.90  Are there exceptions from the requirement of determining
                            </h3>
                            <p class="depth1"><em>(a)</em> Donor-eligibility determination not required. You are not  required to make a donor-eligibility determination under Sec. 1271.50  or to perform donor screening or testing under Sec. Sec. 1271.75,  1271.80 and 1271.85 for:</p><p class="depth2"><em>(1)</em> Cells and tissues for autologous use; or</p><p class="depth2"><em>(2)</em> Reproductive cells or tissue donated by a sexually intimate  partner of the recipient for reproductive use; or</p><p class="depth2"><em>(3)</em> Cryopreserved cells or tissue for reproductive use, other than  embryos, originally exempt under paragraphs (a)(1) or (a)(2) of this  section at the time of donation, that are subsequently intended for  directed donation, provided that</p><p class="depth3"><em>(i)</em> Additional donations are unavailable, for example, due to the  infertility or health of a donor of the cryopreserved reproductive cells  or tissue; and</p><p class="depth3"><em>(ii)</em> Appropriate measures are taken to screen and test the donor(s)  before transfer to the recipient.</p><p class="depth2"><em>(4)</em> A cryopreserved embryo, originally exempt under paragraph (a)(2)  of this section at the time of cryopreservation, that is subsequently  intended for directed or anonymous donation. When possible, appropriate  measures should be taken to screen and test the semen and oocyte donors  before transfer of the embryo to the recipient.</p><p class="depth1"><em>(b)</em> Required labeling. As applicable, you must prominently label an  HCT/P described in paragraph (a) of this section as follows:</p><p class="depth2"><em>(1)</em> ``FOR AUTOLOGOUS USE ONLY,'' if it is stored for autologous use.</p><p class="depth2"><em>(2)</em> ``NOT EVALUATED FOR INFECTIOUS SUBSTANCES,'' unless you have  performed all otherwise applicable screening and testing under  Sec. Sec. 1271.75, 1271.80, and 1271.85. This paragraph does not apply  to reproductive cells or tissue labeled in accordance with paragraph  (b)(6) of this section.</p><p class="depth2"><em>(3)</em> Unless the HCT/P is for autologous use only, ``WARNING: Advise  recipient of communicable disease risks,''</p><p class="depth3"><em>(i)</em> When the donor-eligibility determination under Sec. 1271.50(a)  is not performed or is not completed; or</p><p class="depth3"><em>(ii)</em> If the results of any screening or testing performed indicate:</p><p class="depth4"><em>(A)</em> The presence of relevant communicable disease agents and/or</p><p class="depth4"><em>(B)</em> Risk factors for or clinical evidence of relevant communicable  disease agents or diseases.</p><p class="depth2"><em>(4)</em> With the Biohazard legend shown in Sec. 1271.3(h), if the  results of any screening or testing performed indicate:</p><p class="depth3"><em>(i)</em> The presence of relevant communicable disease agents and/or</p><p class="depth3"><em>(ii)</em> Risk factors for or clinical evidence of relevant communicable  disease agents or diseases.</p><p class="depth2"><em>(5)</em> ``WARNING: Reactive test results for (name of disease agent or  disease),'' in the case of reactive test results.</p><p class="depth2"><em>(6)</em> ``Advise recipient that screening and testing of the donor(s)  were not performed at the time of cryopreservation of the reproductive  cells or tissue, but have been performed subsequently,'' for paragraphs  (a)(3) or (a)(4) of this section.  [69 FR 29830, May 25, 2004, as amended at 70 FR 29952, May 25, 2005]</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>.
          Code available <a href="https://github.com/18F/allregs">on Github.
        </a></h5>
        <h5>All regulations are from the 2015 Annual Edition.
          This is a technical demonstration not intended for serious use.</h5>
      </div>
    </div>
  </footer>
  </body>
</html>
